Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study

Clinical trial NCT05692999 · RECRUITING

Trial details

NCT number: NCT05692999
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Non-squamous Lung Cancer

Start date: 2023-03-20
Primary completion: 2029-01-01
Enrollment: 1166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.